PDCD1 and melanoma: In this study, using the syngeneic melanoma model in immunocompetent mice and a series of cognitive function tests, we demonstrate that blockade of CTLA-4 and PD-1 impedes hippocampal-dependent cognitive function by altering the immune landscape of the brain and activating microglia, resulting in neuroinflammation-mediated neurodegeneration.